LinkedIn Live: Two Years On with Bassil Akra: The MDR Has Changed, and So Has He

CommuniD followed up with Dr. Bassil Akra about the future of the MDR and what the December 2025 revision really means for MedTech companies.

This is now more than just a discussion about deadlines or compliance. Instead, the conversation is shifting towards:

• Digitalisation of regulatory systems
• The resilience of the European MedTech ecosystem
• The real operational impact on manufacturers
• How AI and digital tools will support — but not replace — regulatory expertise

The companies preparing now for 2027 are rethinking how regulatory, quality, and digital infrastructure work together — not simply updating documentation.